SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 162 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q4 2016. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $9,000 | -86.8% | 40,500 | 0.0% | 0.00% | -81.8% |
| Q3 2018 | $68,000 | -5.6% | 40,500 | 0.0% | 0.02% | -15.4% |
| Q2 2018 | $72,000 | -2.7% | 40,500 | 0.0% | 0.03% | -13.3% |
| Q1 2018 | $74,000 | -12.9% | 40,500 | +5.3% | 0.03% | -16.7% |
| Q4 2017 | $85,000 | +97.7% | 38,450 | +127.5% | 0.04% | +80.0% |
| Q3 2017 | $43,000 | -12.2% | 16,900 | +39.1% | 0.02% | -16.7% |
| Q2 2017 | $49,000 | 0.0% | 12,150 | 0.0% | 0.02% | -11.1% |
| Q1 2017 | $49,000 | -35.5% | 12,150 | +4.3% | 0.03% | -46.0% |
| Q4 2016 | $76,000 | +65.2% | 11,650 | -4.3% | 0.05% | +38.9% |
| Q2 2016 | $46,000 | +35.3% | 12,175 | -3.6% | 0.04% | +33.3% |
| Q1 2016 | $34,000 | -54.1% | 12,625 | -21.6% | 0.03% | -62.0% |
| Q1 2015 | $74,000 | +42.3% | 16,100 | -5.8% | 0.07% | +18.3% |
| Q4 2014 | $52,000 | – | 17,100 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 3,273,509 | $9,493,000 | 1.85% |
| Trellus Management Company, LLC | 362,500 | $1,051,000 | 1.44% |
| Paulson & Co. | 24,062,368 | $69,781,000 | 1.25% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 971,922 | $2,799,000 | 1.09% |
| Asymmetry Capital Management, L.P. | 271,102 | $786,000 | 0.91% |
| Cheyne Capital Management (UK) LLP | 651,500 | $1,880,000 | 0.68% |
| Hikari Power Ltd | 1,500,000 | $4,350,000 | 0.56% |
| Orbimed Advisors | 13,621,443 | $39,502,000 | 0.38% |
| CARL DOMINO INC | 83,000 | $241,000 | 0.29% |
| KNOTT DAVID M | 158,400 | $459,000 | 0.20% |